|
Forecast Period
|
2026-2030
|
|
Market Size (2024)
|
USD
628.32 Million
|
|
CAGR (2025-2030)
|
8.45%
|
|
Fastest Growing Segment
|
Infectious
Disease
|
|
Largest Market
|
South India
|
|
Market Size (2030)
|
USD 1,024.57 Million
|
Market Overview
India Point of Care Diagnostics Market
was valued at USD 628.32 Million in 2024 and is expected to reach USD 1,024.57 Million
by 2030 with a CAGR of 8.45% during the forecast period.
The India Point of Care (POC) Diagnostics Market is witnessing strong growth due to rising healthcare needs and technological advancements. The increasing prevalence of chronic diseases such as diabetes and cardiovascular conditions, along with a growing burden of infectious diseases, is driving demand for fast and efficient diagnostic solutions.
Expanding healthcare infrastructure in rural areas, supported by initiatives like Ayushman Bharat, is improving access to POC testing. Technological innovations, including mobile health integration and portable devices, are enhancing accuracy and convenience across urban and rural regions. However, high device costs, regulatory challenges, limited reimbursement policies, low awareness in rural areas, and concerns over device quality remain key barriers, despite rising health consciousness boosting adoption.
Key Market Drivers
Rising
Prevalence of Chronic Diseases
India is facing a sharp rise in chronic diseases, which is driving the growth of the Point of Care (POC) diagnostics market. Conditions such as hypertension, diabetes, and cardiovascular diseases are becoming more common, especially in urban areas where poor diet, lack of exercise, and stress are widespread.
This growing burden highlights the urgent need for accessible and timely diagnostic solutions. POC diagnostics allow early detection and continuous monitoring, supporting better disease management and reducing strain on healthcare systems, especially in areas with limited resources. The demand for cost-effective and quick testing solutions is expected to rise further as chronic conditions continue to increase..
Growing
Aging Population
India’s expanding elderly population is another major factor driving the POC diagnostics market. With longer life expectancy and an increasing proportion of people aged 60 and above, the need for healthcare solutions tailored to older adults is growing. Elderly individuals are more vulnerable to chronic conditions and require regular monitoring and convenient access to diagnostic tools.
The United Nations Population Fund (UNFPA) reported that in 2021, 10.1% of India’s population was aged 60 or above. This share is projected to reach 19.5% by 2050, nearly tripling the number of elderly individuals. Data from the National Sample Survey Organization (NSSO) shows that more than 70% of older adults in India live with at least one chronic disease.
Point-of-care diagnostics provide practical solutions for this demographic by offering fast, reliable, and affordable testing. Devices such as blood glucose meters, cholesterol monitors, and blood pressure machines enable better disease management at home, in rural areas, and in long-term care facilities. These technologies reduce hospital visits and improve quality of care for elderly patients.
With the elderly population growing rapidly, demand for POC diagnostics will continue to rise, making them essential to managing chronic diseases and meeting the healthcare needs of aging communities in India.
Download Free Sample Report
Key Market Challenges
Limited
Awareness and Education
Limited awareness and education about Point of Care
(POC) diagnostics remain significant challenges to the widespread adoption of
these technologies in India. While urban areas have seen growing awareness of
the benefits and convenience offered by POC diagnostics, rural and remote
regions lag behind in understanding how these devices can improve healthcare
outcomes. Many healthcare professionals in smaller clinics, particularly in
underserved areas, may not be familiar with the latest advancements in POC
technologies or may lack proper training on how to effectively use these
devices. This gap in knowledge creates a barrier to integrating POC diagnostics
into daily healthcare practices.
Additionally, patients themselves may not fully
understand the importance of rapid, in-situ testing for early disease detection
and management, leading to hesitancy in utilizing POC services. This lack of
awareness often results in underutilization of POC diagnostics, especially in
rural regions where access to advanced healthcare facilities is limited.
Increasing education and awareness about the potential benefits and proper
usage of POC devices, both for healthcare professionals and patients, is essential
to boost adoption and ensure that these technologies are fully leveraged to
improve healthcare accessibility and outcomes across India.
Key Market Trends
Technological
Advancement
Technological innovation is transforming point-of-care diagnostics in India by enabling faster, portable, and decentralized testing closer to patients. This shift is reflected in the National Essential Diagnostics List, which includes rapid tests for facilities like Ayushman Arogya Mandirs and primary healthcare centers.
Digital connectivity plays a key role, with initiatives such as the Technology Development Board supporting IoT-enabled, AI-powered platforms like Primary Healthtech’s blood testing device, capable of conducting multiple tests simultaneously and validated on 10,000 patients. Mobile Medical Units further enhance outreach by delivering diagnostics to remote areas.
Advancements in miniaturization, biosensors, and microfluidics are improving portability, accuracy, and efficiency. Industry efforts, including widespread deployment of Truenat systems, highlight scaling adoption across India.
Segmental Insights
Product
Insights
Based on Product, Infectious Disease emerged as the fastest growing segment in the India Point of Care Diagnostics
Market in 2024. This is due to a combination of factors, particularly the
rising incidence of infectious diseases and the increasing demand for rapid,
on-site diagnostic solutions. Infectious diseases such as tuberculosis,
malaria, hepatitis, dengue, and COVID-19 remain prevalent across India, with
significant outbreaks occurring periodically.
The urgency of diagnosing these
diseases quickly to ensure timely treatment and prevent further transmission
has highlighted the need for POC diagnostic tools. These devices allow
healthcare providers to quickly detect infections in a variety of settings,
including rural and remote areas where traditional laboratory services may not
be readily available.
The COVID-19 pandemic further accelerated the growth
of the Infectious Disease segment, as POC testing became a critical tool for
mass testing, monitoring, and controlling the spread of the virus. As a result,
there has been an increased focus on the development and adoption of portable,
user-friendly diagnostic devices capable of providing results in a matter of
minutes. Beyond COVID-19, the ongoing concerns over diseases like tuberculosis,
HIV, and vector-borne diseases such as dengue and malaria are driving demand
for faster and more efficient diagnostic solutions.
End
Use Insights
Based on End Use, Home emerged as
the fastest growing segment in the India Point of Care Diagnostics Market
during the forecast period. due to a combination of factors that reflect the
changing healthcare dynamics in the country. The increasing preference for
at-home healthcare solutions, driven by convenience, cost-effectiveness, and
the desire for timely results, has significantly contributed to the rise of
home care diagnostics. With more people seeking to monitor their health
independently, especially for chronic conditions such as diabetes,
hypertension, and heart disease, home diagnostic tools have become an essential
part of personal healthcare management.
Advancements in technology, particularly the
development of user-friendly devices like blood glucose meters, home pregnancy
tests, cholesterol monitors, and pulse oximeters, have made it easier for
individuals to perform tests without requiring professional assistance. These
devices are designed to be simple, accurate, and accessible, empowering
patients to take control of their health. For instance, continuous glucose
monitoring systems, which were once primarily used in hospitals, are now
available for home use, allowing diabetic patients to track their blood sugar
levels regularly.
Download Free Sample Report
Regional Insights
South India emerged as the dominant region in the India Point of Care (POC) Diagnostics Market in 2024, driven by evolving healthcare dynamics. The region benefits from advanced healthcare infrastructure, high urbanization, and strong investments in healthcare technology. Major cities such as Bengaluru, Chennai, Hyderabad, and Kochi host well-established hospitals, clinics, and diagnostic centers that increasingly adopt POC solutions for their efficiency and convenience.
A high concentration of healthcare professionals and active research in medical technologies further supports innovation and adoption. Additionally, a growing middle class, rising healthcare spending, and strong educational systems contribute to market expansion. Increased awareness of chronic and infectious diseases, along with a focus on preventive healthcare, continues to drive demand for POC diagnostics.
Recent Development
- In March 2026, Co-Diagnostics shipped PCR Pro instruments, Co-Dx PCR MTB tuberculosis test kits, and sample-preparation instruments to its Indian joint venture CoSara Diagnostics to begin clinical performance studies in India. The company said the programme aligns with newer WHO recommendations on near-point-of-care molecular diagnostics for TB, and it added that the PCR Pro instrument had already received a CDSCO license to be manufactured and sold in India. This was an important collaboration-driven development because it moved a portable molecular TB-testing platform closer to local validation and potential commercialization in one of the world’s highest-burden tuberculosis markets.
- In September 2025, AliveCor launched its Kardia 12L system in India, describing it as the world’s first AI-powered handheld 12-lead ECG device with a single-cable design. The CDSCO-approved device was designed for healthcare professionals, can detect 35 cardiac determinations including acute myocardial infarction and ischemia, and is battery-operated, pocket-sized, and simpler to use than conventional 12-lead ECG machines. This launch was significant for the point-of-care diagnostics market because it brought high-acuity cardiac testing into a more portable format that can support faster bedside or clinic-based decision-making.
- In September 2025, Punjab launched AI-enabled portable screening devices for early detection of breast cancer, cervical cancer, and refractive errors in a programme implemented in collaboration with ACT Grants across eight districts. The deployment brought together several point-of-care tools, including Niramai’s Thermalytix for breast cancer screening, Periwinkle’s Smart Scope for cervical cancer screening, and Forus Health’s portable autorefractometer for vision checks, all intended for use in primary health settings. The initiative mattered because it showed how state health systems in India are beginning to use portable, rapid, and non-invasive diagnostics to shift screening closer to communities rather than relying only on hospital-based infrastructure.
- In August 2025, the Technology Development Board of the Department of Science and Technology signed an agreement with Primary Healthtech to support development of an IoT-enabled, AI-powered point-of-care blood testing device for affordable primary-care diagnostics in India. The project aimed to upgrade the company’s Mobilab platform so it could run five tests simultaneously and expand its menu to parameters such as hemoglobin, creatinine, bilirubin, cholesterol, triglycerides, uric acid, glucose, and GGT, while also moving toward commercial-scale manufacturing. This was a notable collaboration-led development because it linked government funding with an indigenous portable diagnostics platform designed for decentralized testing in underserved settings.
Key Market Players
|
By Product
|
By End Use
|
By Region
|
- Glucose Testing
- Hb1Ac Testing
- Coagulation Testing
- Fertility/Pregnancy
- Infectious Disease
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Others
|
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratory
|
- East India
- West India
- North India
- South India
|
Report Scope
In this report, the India Point of Care Diagnostics
Market has been segmented into the following categories, in addition to the
industry trends which have also been detailed below:
- India Point of Care
Diagnostics Market, By
Product:
o Glucose Testing
o Hb1Ac Testing
o Coagulation Testing
o Fertility/Pregnancy
o Infectious Disease
o Cardiac Markers
o Thyroid Stimulating Hormone
o Hematology
o Primary Care Systems
o Others
- India Point of Care
Diagnostics Market, By
End Use:
o Clinics
o Hospitals
o Home
o Assisted Living Healthcare Facilities
o Laboratory
- India Point of Care
Diagnostics Market, By Region:
o East India
o West India
o North India
o South India
Competitive Landscape
Company Profiles: Detailed analysis of the major companies
present in the India Point of Care Diagnostics Market.
Available Customizations:
India Point of Care Diagnostics Market report with
the given market data, Tech Sci Research offers customizations according to a
company's specific needs. The following customization options are available for
the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
India Point of Care Diagnostics Market is an
upcoming report to be released soon. If you wish an early delivery of this
report or want to confirm the date of release, please contact us at [email protected]